Regulation of immune responses, apoptosis, and tumorigenesis by separate FOXP-3-dependent genes: Connection with clinical manifestations

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 6, 2011, Pages 412-417

  Klimenko, Oxana V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

FOXP 3; IPEX; Tregs

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

APOPTOSIS; BASIC RESEARCH; CARCINOGENESIS; CLINICAL RESEARCH; GENE FUNCTION; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NEOPLASM; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; SIGNAL TRANSDUCTION; SYNDROME; T-LYMPHOCYTES, REGULATORY;

EID: 83155175388     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.04.007     Document Type: Review

References (40)

1. Ha T.Y., Waksman B.H., Treffers H.P. The thymic suppressor cell. I. Separation of subpopulations with suppressor activity. J Exp Med 1974, 1:13-23.
2. Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Gen 2002, 39:537-545.
3. Clark L.B., Appleby M.W., Brunkow M.E., Wilkinson J.E., Ziegler S.F., Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 1999, 162:2546-2554.
4. + regulatory T cells in autoimmune diseases. Nat Clin Prac Rheumatol 2007, 3:619-626.
5. Sugimoto N., Oida T., Hirota K., Nakamura K., Nomura T., Uchiyama T., et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 2006, 18:1197-1209.
6. Zheng Y., Oida T., Hirota K., Nakamura K., Nomura T., Uchiyama T., et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Lett Nat 2007, 445:936-940.
7. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunology 2007, 27:786-800.
8. Bayry J. Autoimmunity: CTLA-4: a key protein in autoimmunity. Nat Rev Rheumatol 2009, 5:244-245.
9. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
10. Zheng S.G., Wang J.H., Stohl W., Kim K.S., Gray J.D., Horwitz D.A. TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 2006, 176:3321-3329.
11. Holmberg D., Cilio C.M., Lundholm M., Motta V. CTLA-4 (CD152) and its involvement in autoimmune disease. Autoimmunity 2005, 38:225-233.
12. Wei C.-M., Lee J.-H., Wang L.-C., Yang Y.-H., Chang L.-Y., Chiang B.-L. Frequency a phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis. J Microbiol Immunol Infect 2008, 41:78-87.
13. Strauss L., Bergmann C., Szczepanski M.J., Lang S. Expression of ICOS on human melanoma-infiltrating CD4+CD25high Foxp3+T regulatory cells: implications and impact on tumor-mediated immune suppression. J Immunol 2008, 108:2967-2980.
14. van Berkel M.E.A.T., Oosterwegel M.A. CD28 and ICOS: similar or separate co-stimulators of T cells?. Immunol Lett 2006, 105:115-122.
15. Honkanen J., Skarsvik S., Knip M., Vaarala O. Poor in vitro of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes. Diabetes Metab Res Rev 2008, 24:635-641.
16. Bodor J., Fehervari Z., Diamond B., Sakaguchi S. Regulatory T cell-mediated suppression: potential role of ICER. J Leukoc Biol 2007, 81:161-167.
17. Rudensky A.Y., Gavin M., Zheng Y. FOXP3 and NFAT: partners in tolerance. Cell 2006, 126:253-256.
18. Chakraborty K., Maity P.C., Sil A.K., Takeda Y., Das S. cAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor. J Biol Chem 2009, 284:21810-21827.
19. Bodor J., Fehervari Z., Diamond B., Sakaguchi S. ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur J Immunol 2007, 37:884-895.
20. Huggins G.S., Lepore J.J., Grytak S., Patten R., McNamee R., Aronovitz M., et al. The CREB leucine zipper regulates CREB phosphorylation, cardiomyopathy, and lethality in a transgenic model of heart failure. Am J Pathol 2007, 293:H1877-H1882.
21. Seddiki N. Blimp-1/Prdm1 is preferentially expressed in subsets of antigen-expressed regulatory T cells. Clin Immunol 2009, 131:S32.
22. Martins G.A., Cimmino L., Liao J., Magnusdottir E., Calame K. Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J Exp Med 2008, 205:1959-1965.
23. Santer-Nanan B., Berberich-Siebelt F., Xiao Z., Poser N., Sennefelder H., Rauthe S., et al. Blimp-1 is expressed in human and mouse T cell subsets and leads to loss of IL-2 production and to defective proliferation. Sign Transduct 2006, 6:268-279.
24. Lu H. FOXP3 expression and prognosis: role of both the tumor and T cells. J Clin Oncol 2009, 27:1735-1736.
25. Heinze E., Baldwin S., Chan G., Hansen J., Song J., Clements D., et al. Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo. Int J Oncol 2009, 35:167-173.
26. de Boer O.J., van der Loos C.M., Teeling P., van der Wal A.C., Teunissen M.B.M. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25 + T cells in normal skin and inflammatory dermatoses. J Hystochem Cytochem 2007, 55:891-898.
27. Esparza E.M., Arch R.H. Glucocorticoid-induced TNF receptor, a co-stimulatory receptor on naïve and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-{kappa}B activation. J Immunol 2005, 174:7875-7882.
28. Wang L., Pino-Lagos K., de Vries V.C., Guleria I., Sayegh M.H., Noelle R.J. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. PNAS 2008, 105:9331-9336.
29. Wang W., Lau R., Yu D., Zhu W., Korman A., Weber J. PD1 blockade reverses suppression of melanoma antigen-specific CTL by CD4+CD25(Hi) regulatory T cells. Int Immunol 2009, 21:1065-1077.
30. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., et al. PD-1 is a regulator of virus-specific CD8 + T cell survival in HIV infection. J Exp Med 2006, 203:2281-2292.
31. Candotti F., Notarangelo L. Autosomal recessive severe combined immunodeficiency due to defects in cytokine signaling pathways. Primary immunodeficiency diseases: a molecular and genetic approach 2007, 145-146. Oxford University Press, New York. H.D. Ochs, C.I.E. Smith, J.M. Puck (Eds.).
32. Liu W., Putnam A.L., Xu-yu Z., Szot G.L., Lee M.R., Zhu, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + Treg cells. J Exp Med 2006, 203:1701-1711.
33. Shen L.S., Wang J., Shen D.F., Yuan X.L., Dong P., Li M.X., et al. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancer progression. Clin Immunol 2009, 131:109-118.
34. Bielenberg D.R., Pettaway C.A., Klagsburn M. Neuropilins: expression, regulation, and function. Exp Cell Res. 2006, 312:584-593.
35. Hansen W., Loser K., Westendorf A.M., Bruder D., Pfoertner S., Siewert C., et al. G protein-coupled receptor 83 overexpression in naïve CD4+CD25-T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J Immunol 2006, 177:209-215.
36. Jia H., Cheng L., Tickner M., Bagherzadeh A., Selwood D., Zachary I. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br J Cancer 2010, 102:541-552.
37. Li X., Ye F., Chen H., Lu W., Wan X., Xie X. Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta. Cancer Lett 2007, 253:144-153.
38. Chen T., Jackson C., Costello B., Singer N., Colligan B., Douglass L., et al. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 2004, 10:420-425.
39. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007, 13:108-116.
40. Wang L., Yu J., Ni J., Xu X.-M., Wang J., Ning H., et al. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 2003, 200:57-67.